Sponsored by:
Chairs: Ben Tran and Frank Gardiner
New pre-chemotherapy treatment options for CRPC (#27)
10:30 AM
Bladder cancer decision-making (#28)
10:30 AM
New treatment paradigms in oligometastatic disease (#29)
10:30 AM
Percutaneous ablation – the new gold standard for small renal masses (#30)
10:30 AM
Challenges in developing RCC therapeutics (#31)
10:30 AM